Top compounds associated with response to EFHB


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.3
mRNA Rapamycin GDSC1000 pan-cancer AAC -0.055 0.3
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA narciclasine CTRPv2 pan-cancer AAC -0.036 0.3
mRNA PD-0332991 GDSC1000 pan-cancer AAC 0.037 0.3
mRNA Z-LLNle-CHO GDSC1000 pan-cancer AAC 0.052 0.3
mRNA YM-155 GDSC1000 pan-cancer AAC 0.037 0.3
mRNA ML258 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA KU 0060648 CTRPv2 pan-cancer AAC -0.038 0.3
Download CSV